Medican Enterprises, Inc. (OTCPK: MDCN)
Health Care · Pharmaceuticals · US
$0.00
-99.00% today · 0.0% 1Y
Medican Enterprises, Inc. (OTCPK: MDCN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $46.55K and employs 3 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores Medican Enterprises, Inc. across four factors: quality 5/100. Its strongest factor is quality.
MDCN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $46.55K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -17.92
- Dividend yield
- —
- Beta (5Y)
- -69.47
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 46.54B
- Employees
- 3
- Next earnings
- —
About Medican Enterprises, Inc.
Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company was founded on October 27, 1988 and is headquartered in Los Angeles, CA.
- ISIN
- US58464T2024
- Founded
- 1988
- Listed since
- Feb 21, 1995
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,237.51 | -1.43% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.91 | +0.25% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.23 | -1.52% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.20 | -1.70% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.54 | -1.52% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.93 | -0.50% |
Figures last refreshed Aug 18, 2026.